The Facts on Homozygous Familial Hypercholesterolemia By The FH Foundation
July 24, 2013
Homozygous Familial Hypercholesterolemia - HoFH
What if you had high cholesterol but diet, exercise and commonly used medications couldn’t lower your cholesterol to a recommended level? This frightening condition is real. It’s called HoFH or Homozygous Familial Hypercholesterolemia, and people inherit it from both of their parents. Watch this “Behind the Mystery: Rare and Genetic Diseases” segment as we talk with Dr. Pamela Morris, Cardiologist, Amanda, a 20 year old patient, and Katherine Wilemon from the FH Foundation about the signs, symptoms and what everyone should know about this condition – including that there are treatment options that have been approved in the last year for adults with this disorder.
Supported by Aegerion Pharmaceuticals
Behind the Mystery is a special segment dedicated to revolutionizing the way the health care system works for those suffering from a rare and genetic disorder.
Behind the Mystery takes a closer look at one of the two types of Polycystic Kidney disease. Autosomal Dominant Polycystic Kidney Disease, or ADPKD, is a rare, genetic condition.
Behind the Mystery takes a closer look at Blastic Plasmacytoid Dendritic Cell Neoplasm, a rare disease that is often misdiagnosed and affects at least 500 to 1,000 patients each year in the U.S.